Showing 1,461 - 1,480 results of 1,601 for search '"Toronto"', query time: 0.06s Refine Results
  1. 1461
  2. 1462

    Hybrid Offset Position Encoding for Large-Scale Point Cloud Semantic Segmentation by Yu Xiao, Hui Wu, Yisheng Chen, Chongcheng Chen, Ruihai Dong, Ding Lin

    Published 2025-01-01
    “…RandLA-Net with HOPE achieved a 1.4% improvement on the large-scale outdoor dataset Toronto3D, all with minimal additional computational cost. …”
    Get full text
    Article
  3. 1463
  4. 1464
  5. 1465
  6. 1466

    Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy rando... by Laurie Zawertailo, Helena Zhang, Noreen Rahmani, Tarek K Rajji, Peter Selby

    Published 2022-01-01
    “…<h4>Methods</h4>This is a double-blind, sham-controlled randomized clinical trial where fifty healthy smokers will be recruited in Toronto, Canada. Participants will be randomized 1:1 to either active tDCS (20 minutes at 2 mA) or sham tDCS (30 seconds at 2 mA, 19 minutes at 0 mA) for 10 daily sessions (2 weeks) plus 5 follow up sessions, occurring every two weeks for 10 weeks. …”
    Get full text
    Article
  7. 1467
  8. 1468
  9. 1469
  10. 1470

    Quality of life prognosis in patients with somatoform disorders with sleep disorders by V.V. Ogorenko, I.I. Makarova, A.V. Shornikov

    Published 2024-12-01
    “…A comprehensive assessment of the patient’s condition was conducted, including clinical-anamnestic, clinical-psychopathological, and psychodiagnostic examinations, supplemented by the use of psychometric scales (Pittsburgh Sleep Quality Index, Beck Depression Inventory, Insomnia Severity Index, Toronto Alexithymia Scale-20, Integrative Quality of Life Questionnaire, and Spielberger Anxiety Scale). …”
    Get full text
    Article
  11. 1471
  12. 1472
  13. 1473
  14. 1474

    Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial. by Biban Gill, Jocelyn M Wessels, Christina L Hayes, Jenna Ratcliffe, Junic Wokuri, Elizabeth Ball, Gregor Reid, Rupert Kaul, Jesleen Rana, Muna Alkhaifi, Wangari Tharao, Fiona Smaill, Charu Kaushic

    Published 2025-01-01
    “…<h4>Methods</h4>ACB women aged 18-49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
    Get full text
    Article
  15. 1475
  16. 1476
  17. 1477
  18. 1478
  19. 1479
  20. 1480